NK cells pretreated with estriol and commensal flora cells regulate the maturation of Treg and Th17 from CD4+ lymphocytes in multiple sclerosis patients and healthy donors

Main Article Content

Irina V. Nekrasova
Natalia S. Glebezdina
Irina L. Maslennikova
Irina Yu. Danchenko
Sergey V. Shirshev

Abstract

Multiple sclerosis (MS) is an inflammatory chronic disease of the central nervous system, one of the pathogenetic mechanisms of which is an immune-mediated attack to the myelin sheath of nerve axons under the control of autoreactive T cells. NK cells, one of subtypes of ILC cells, have the ability to regulate autoimmune mechanisms through the production of cytokines or cytotoxic effects directly against effector cells, such as autoreactive T cells or antigen-presenting cells. At the same time, they can also lyse microglial, astrocyte, and oligodendrocyte cells, indicating a dual function of NK cells in MS. The influence of the pregnancy hormone estriol (E3) and commensal microflora on the ability of NK cells to modulate the level of T regulatory (Treg) and IL-17-producing (Th17) lymphocytes from patients with multiple sclerosis (MS) in comparison with healthy donors was studied. To activate NK cells, Ecsherichia coli K12 and Lactobacillus plantarum 8R-A3 strains were used. The phenotype of Treg and Th17 cells was assessed by flow cytometry using monoclonal antibody staining. It was found that NK cells incubated with E3 and E. coli stimulate the formation of Tregs, and pretreatment of NK cells with L. plantarum inhibits the formation of Th17 from CD4+ lymphocytes. In general, regulatory lymphocytes from MS patients turned out to be more sensitive to the influence of NK cells than cells from healthy donors.

Article Details

How to Cite
Nekrasova И. В. ., Glebezdina Н. С. ., Maslennikova И. Л., Danchenko И. Ю., & Shirshev С. В. (2024). NK cells pretreated with estriol and commensal flora cells regulate the maturation of Treg and Th17 from CD4+ lymphocytes in multiple sclerosis patients and healthy donors. Bulletin of Perm University. Biology, (1), 107–112. https://doi.org/10.17072/1994-9952-2024-1-107-112
Section
Иммунология
Author Biographies

Irina V. Nekrasova , Perm Federal Research Center UB RAS, Perm, Russia

Сandidate of biology, researcher of laboratory of immunoregulation

Natalia S. Glebezdina , Perm Federal Research Center UB RAS, Perm, Russia

Candidate of biology, junior researcher of laboratory of immunoregulation

Irina L. Maslennikova , Perm Federal Research Center UB RAS, Perm, Russia

Сandidate of biology, senior researcher of laboratory of immunoregulation

Irina Yu. Danchenko , E.A. Vagner Perm State Medical University, Perm, Russia

Сandidate of medicine, assistant of the department of neurology and medical genetics

Sergey V. Shirshev , Perm Federal Research Center UB RAS, Perm, Russia

Doctor of medicine, professor, head of laboratory of immunoregulation

References

Некрасова И.В., Ширшев С.В. Женские половые стероидные гормоны в регуляции ферментативной активности нейтрофилов // Доклады Академии наук. 2013. Т. 453, № 6. С. 690–693. DOI: 10.7868/S0869565213360231.

Ширшев С.В., Некрасова И.В. Комплексное исследование иммуномодулирующей активности эстриола // Иммунология. 2011. Т. 32, № 2. С. 72–74.

Ширшев С.В. и др. Влияние хорионического гонадотропина и эстриола на фенотип и функциональную активность NK-клеток // Физиология человека. 2016. Т. 42, № 5. С. 102–107. DOI: 10.7868/S0131164616050143.

Ширшев С.В. и др. Участие микроРНК в гормональных механизмах регуляции функций NK-клеток // Доклады Академии наук. 2017. Т. 474, № 1. С. 123–127. DOI: 10.7868/S0869565217130254.

Ширшев С.В. и др. Гормональная регуляция дифференцировки дендритных клеток тимуса // Бюллетень экспериментальной биологии и медицины. 2018. Т. 165, № 2. С. 193–197.

Aziz N., Bonavida B. Activation of Natural Killer Cells by Probiotics // For Immunopathol. Dis. Therap. 2016. Vol. 7, № 1–2. P. 41–55. DOI: 10.1615/ForumImmunDisTher.2016017095.

Fu B. et al. Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface // Proc. Natl. Acad. Sci. USA. 2013. Vol. 110, № 3. P. E231–240. DOI: 10.1073/pnas.1206322110.

Gross C.C. et al. Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis // Neurol. Neuroimmunol. Neuroinflamm. 2016. Vol. 3, № 6. P. e289. DOI: 10.1212/NXI.0000000000000289.

Harbo H.F., Gold R., Tintore M. Sex and gender issues in multiple sclerosis // Archive of Therapeutic Advances in Neurological Disorders. 2013. Vol. 6, № 4. P. 237–248. DOI: 10.1177/1756285613488434.

Hepworth M.R. et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells // Science. 2015. Vol. 348, № 6238. P. 1031–1035. DOI: 10.1126/science.aaa4812.

Jadidi-Niaragh F., Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis // Scandinavian Journal of Immunology. 2011. Vol. 74, № 1. P. 1–13. DOI: 10.1111/j.1365-3083.2011.02536.x.

Kase N.G., Reyniak J.V. Endocrinology of pregnancy // Mount Sinai Journal of Medicine. 1985. Vol. 52, № 1. P. 11–34.

McDonald W.I. et al. Recommended diagnostic criateria for multiple sclerosis: guidelines for the International Panel on diagnosis of multiple sclerosis // Annals of Neurology. 2001. Vol. 50, № 1. P. 121–127. DOI: 10.1002/ana.1032.

Nekrasova I., Shirshev S. Estriol in regulation of cell-mediated immune reactions in multiple sclerosis // Journal of Neuroimmunology. 2020. Vol. 349C. P. 577421. DOI: 10.1016/j.jneuroim.2020.577421.

Neuteboom R.F. et al. Pregnancy in multiple sclerosis: clinical and self-report scales // Journal of Neurology. 2012. Vol. 259. P. 311–317. DOI: 10.1007/s00415-011-6186-7.

Papenfuss T.L. et al. Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity // Journal of Immunology. 2011. Vol. 186, № 6. P. 3346–3355. DOI: 10.4049/jimmunol.1001322.

Pelfrey C.M. et al. Effects of sex hormones on costimulatory molecule expression in multiple sclerosis // Journal of Neuroimmunology. 2005. Vol. 167, № 1–2. P. 190–203. DOI: 10.1016/j.jneuroim.2005.06.014.

Sicotte N.L. et al. Treatment of multiple sclerosis with the pregnancy hormone estriol // Annals of Neurology. 2002. Vol. 52, № 4. P. 421–428. DOI: 10.1002/ana.10301.

Soldan S.S. et al. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol // Journal of Immunology. 2003. Vol. 171. P. 6267–6274. DOI: 10.4049/jimmunol.171.11.6267.

Vacca P. et al. Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression // Proc. Natl. Acad. Sci. USA. 2010. Vol. 107, № 26. P. 11918–11923. DOI: 10.1073/pnas.1001749107.

von Burg N. et al. Maintenance of Immune Homeostasis through ILC/T Cell Interactions // Front Immunol. 2015. Vol. 6. P. 1–13. DOI: https://doi.org/10.3389/fimmu.2015.00416.

Voskuhl R.R. et al. Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial // Lancet Neurology. 2016. Vol. 15, № 1. P. 35–46. DOI: 10.1016/S1474-4422(15)00322-1.

Xu L., Kitani A., Strober W. Molecular mechanisms regulating TGF-βІ-induced Foxp3 expression // Mu-cosal Immunology. 2010. Vol. 3, № 3. P. 230–238. DOI: 10.1038/mi.2010.7.